U.S. Markets closed

Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
37.91-0.05 (-0.13%)
At close: 4:00PM EDT

37.91 0.00 (0.00%)
After hours: 4:14PM EDT

People also watch
EPZMFPRXXLRNMGNXOMED
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue9/30/20169/30/20159/30/2014
Total Revenue88,268160,88047,741
Cost of Revenue---
Gross Profit88,268160,88047,741
Operating Expenses
Research Development40,46123,18918,740
Selling General and Administrative16,96613,54310,016
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss30,841124,14818,985
Income from Continuing Operations
Total Other Income/Expenses Net1,7641,315301
Earnings Before Interest and Taxes32,605125,46319,286
Interest Expense45818
Income Before Tax32,560125,45519,268
Income Tax Expense10,89446,463-15,170
Minority Interest---
Net Income From Continuing Ops21,66678,99234,438
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income21,66678,99234,438
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares21,66678,99234,438